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Dear Editor,
Autoimmune disorders can be a risk factor for the
development of lymphoma [1], and at the same time,
malignant lymphoma can present with paraneoplastic
syndromes consisting of autoimmune phenomena and even
full-blown rheumatoid disorders [2]. When a patient
presents with predominant clinical symptoms of autoim-
mune disease awareness is necessary in order not to miss an
underlying lymphoma. In this paper, we present a case that
illustrates the difficulties encountered diagnosing malignant
lymphoma when autoimmune phenomena dominate the
clinical presentation.
A 53-year old woman was referred to our hospital for a
second opinion. Seven months earlier, she had been
admitted elsewhere because of intermittent fevers, rigors,
night sweats, anorexia, weight loss, myalgia, arthralgia, and
a maculopapular rash. Before this, there was no relevant
medical history. On physical examination, no pathological
lymph nodes, splenomegaly, or hepatomegaly was present.
Laboratory investigation revealed a leukocytosis (34.7×
109/l) with 90% neutrophils, elevated C-reactive protein
(222 mg/l), liver test abnormalities [alkaline phosphatase
(168 U/l), aspartate transaminase (76 U/l), alanine transami-
nase (49 U/l)], elevated lactate dehydrogenase (910 U/l),
and hyperferritinemia (9,409 μmol/l). Additional laboratory
tests and serology did not show signs of rheumatoid
diseases, sarcoidosis, viral, or bacterial infections (e.g.,
Epstein–Barr virus (EBV), cytomegalovirus, parvovirus,
human immunodefficiency virus, mycoplasma, and borre-
lia). Computer tomography (CT) revealed two small lymph
nodes in the left axilla, but a biopsy failed to acquire
representative material. Eventually, the diagnosis of adult
onset Still’s disease (AOSD) was made because she met
almost all criteria for this disease and no signs of a
lymphoproliferative disease were found (Table 1) [3].
Treatment was started with prednisone (30 mg once daily),
resulting in rapid clinical recovery.
August 2006, the patient was referred because lymphocy-
tosis (absolute lymphocyte count, 5.7×109/l) was noticed
repeatedly during follow up, not accompanied by physical
complaints or signs or cytopenias. After the prednisone was
tapered and finally stopped, with immunophenotyping of
peripheral blood (CD5, CD19, CD20, CD23, and Ig lambda
positive), the diagnosis of a B-cell chronic lymphatic
leukemia (B-CLL) could be established, with RAI stage 0,
not necessitating therapy. A relation with the prior diagnosis
of AOSD was not considered.
In November 2006, she was readmitted because she
experienced a recurrence of the same complaints earlier
resulting in the diagnosis of AOSD. Again, leukocytosis
(26.8×109/l) with predominantly neutrophils (90%) and 8%
lymphocytes was seen. A skin biopsy revealed aspecific
dermatitis compatible with AOSD. Because of high fever
causing headaches, treatment with naproxen and para-
cetamol was initiated without benefit. Bone marrow biopsy
confirmed the earlier diagnosed B-CLL showing small foci
of lymphocytic B cells with expression of CD5 and CD23
(Fig. 1a,b). CT now revealed generalized lymphadenopathy
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and splenomegaly. A surgical excision of an enlarged
axillary lymph node was performed (Fig. 1c,d). Prominent
paracortical expansion and infiltration of immunoblastic T
lymphocytes (Fig. 1e) was seen admixed with large CD20,
CD79a, IgA, and partially CD30-positive blastic B lym-
phocytes (Fig. 1f). The B lymphocytes were negative for
CD5, CD23, and EBV. While clonal immunoglobulin gene
rearrangements were detected, no clonal rearrangements of
the T-cell receptor genes were found, finally confirming the
diagnosis of diffuse large B-cell lymphoma (DLBCL).
Within the clinical context, this was regarded as a
transformation of the B-CLL, the so-called Richter’s
syndrome, following 10 months after the diagnosis of
AOSD. After initiation of combination chemotherapy
[cyclophosphamide, doxorubicin, vincristine, and predni-
sone (CHOP)] and rituximab, the patient recovered rapidly
with normalization of the laboratory abnormalities and the
lymphadenopathy. Since the completion of eight courses of
R-CHOP, she remains in complete remission and without
symptoms, now for more than 12 months.
To our knowledge, this is the first case report on
Richter’s syndrome in a patient with AOSD. Our patient
probably had AOSD that was complicated by the develop-
ment of a B-CLL, which later transformed to a DLBCL,
because at presentation no evidence was found of lympho-
ma. The presence of a “subclinical” CLL at disease onset
cannot be excluded since no immunoflowcytometry studies
were performed on the blood at that time. Autoimmune
diseases are known to precede the occurrence of malignant
lymphoma [1], and there are, although few, reports on
AOSD preceding lymphoma [4, 5]. However, the time
interval between the development of the Richter’s syn-
drome and the initial diagnosis of AOSD in this case was
rather short, which is 10 months, realizing that the time
interval for lymphomas to occur in autoimmune disorders
are rather in the range of many years.
On the contrary, CLL and DLBCL can present with
autoimmune phenomena, but these consist predominantly
of autoimmune cytopenias, such as autoimmune hemolytic
anemia, idiopathic thrombocytopenia, and less common,
pure red cell aplasia and neutropenia [6]. Polymorphous
autoimmune phenomena do occur in lymphoma, and even
reports on lymphoma masquerading AOSD exist, although
extremely rare, but in most of these reports, T-cell
lymphoma seem to be involved [7]. An association between
B-CLL or DLBCL and polymorphous autoimmune phe-
nomena such as AOSD has not yet been described.
Theoretically, it might be possible for B-cell lymphomas
to induce polymorphous autoimmune diseases. The role of
B lymphocytes extends beyond producing antibodies, as
they are antigen-presenting cells and producers of cyto-
kines, activating and altering the function of T lympho-
cytes, and their role in the pathogenesis of autoimmune
disorders mediated by T lymphocyte deregulation has been
established [8]. In our patient, this course of events is
however unlikely because symptoms of AOSD clearly
preceded the diagnosis of lymphoma.
The diagnosis of AOSD often poses great difficulty
because the disease can mimic many other diseases, such as
systemic infections, vasculitis syndromes, and malignan-
cies. Therefore, the final diagnosis must not only rely on
the presence of several clinical features but also on firm
exclusion of other diseases including lymphoproliferative
disorders (Table 1) [3]. Furthermore, during follow-up,
changing, new, or worsening clinical symptoms could result
from lymphoma complicating AOSD creating again a
diagnostic problem. On pathological examination, enlarged
lymph nodes, as seen in 50–60% of AOSD, are difficult to
differentiate from lymphoma on pathological examination,
especially from T-cell lymphoma [9]. In our patient, during
follow-up, the occurrence of lymphadenopathy created the
same problem. The predominant infiltrate in her lymph
node biopsy consisted of a mixture of immunoblastic B and
T cells, as reported before in AOSD [10], with only a
minority of B-cell blasts, first suggesting the differential
diagnosis of a reactive lymph node or a T-cell lymphoma.
Table 1 Criteria for diagnosing AOSD
Criteria
Major criteria
Fever of 39°C or higher, lasting one week or longer
Arthralgia lasting two weeks or longer
Typical rash*






Negative RF and negative ANA***
Exclusion criteria
Infection (especially sepsis and infectious mononucleosis)
Malignancies (especially malignant lymphoma)
Other rheumatoid diseases (especially polyarteritis nodosa, and
rheumatoid vasculitis with extraarticular features)
Classification of AOSD requires five or more criteria including two or
more major criteria. Any disease listed under “exclusions” should be
absent. All criteria are applicable only in absence of other clinical
explanations.
aMacular or maculopapular non-pruritic salmon pink eruption usually
appearing during fever
b Lymphadenopathy is defined as recent development of significant
lymph node swelling, and splenomegaly is confirmed on palpation or
by echogram.
c Rheuma factor (RF) is serum that must be negative by routine test for
the detection of IgM RF, and serum antinuclear antibodies (ANA)
must be negative by routine immunofluorescence test.
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Determining an aberrant B-lymphocyte population by
showing clonal immunoglobulin gene rearrangements was
essential for the final diagnose of Richter’s syndrome.
No strict recommendations exist on the extent of inves-
tigations that are required to exclude lymphoma before
diagnosing AOSD. Furthermore, currently, no guidelines exist
on screening for lymphoma in patients with autoimmune
diseases in general, probably because the absolute incidence is
low despite a substantial increased risk. In addition, it might
be difficult to detect lymphoma in an early stage in patients
with multiple aspecific symptoms, as mentioned earlier.
Therefore, in practice, to avoid missing underlying lympho-
mas, extreme vigilance at diagnosis and during follow up is
necessary. In case there is a changing or unusual clinical
course, especially regarding lymphadenopathy, thorough
investigations are obligatory including histopathology and
immunophenotyping of blood, bone marrow, and lymph node
biopsy. The determination of an aberrant or clonal lymphocyte
population is of utmost importance in finally differentiating
between autoimmune diseases and lymphoma.
Fig. 1 Pathological examina-
tion of bone marrow and lymph
node of the patient. Histology of
the CLL in the bone marrow
biopsy (a HE ×40, b CD23 ×40)
and the transformation in the
axillary lymph node (c HE ×20,
d HE ×40, e CD3 ×40, f CD20
×40). The blastic B-cell prolif-
eration (f) is accompanied by
immunoblastic T-cells in the
background (e)
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